ArticleEpilepsia open2025
Green epileptology: Acceptance of telemedical follow-up under climate protection aspects.
Article in Epilepsia open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Green epileptology: Acceptance of telemedical follow-up under climate protection aspects.Epilepsia open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveExpanding telemedicine services could reduce healthcare's environmental impact. This study aimed to assess the factors influencing the acceptance of telemedical follow-up in epilepsy care, with a particular focus on transportation methods, digital literacy, and environmental awareness.
methodsThe study surveyed adult patients treated at the Department of Epileptology, University Hospital Bonn, by using a 28-item questionnaire which assessed demographics, epilepsy characteristics, transportation, appointment preferences (including telemedicine), computer proficiency, online behavior, and environmental awareness.
resultsA total of 357 participants (54.6% female, 42% seizure-free, 83.8% on ASM) participated in the survey. Most (69.8%) preferred only in-person visits, 26.1% favored a hybrid model, and 4.1% preferred telemedicine exclusively. Digital literacy was high, with two-thirds reporting moderate to high proficiency in online skills, and three-quarters showed concern for environmental issues. Despite this, in-person visits remained the preferred option. Key disadvantages of telemedicine included lack of personal interaction (54.1%) and no blood tests (51.5%), whereas benefits included time savings (42.6%) and avoiding travel (52.7%). Concerns about missing in-person interaction were linked to lower telemedicine acceptance. In contrast, reduced infection risk, workplace absence, and travel avoidance, and environmental benefits were associated with a preference for a hybrid model. SIGNIFICANCE: Although participants expressed environmental awareness, their preference for in-person care highlights the gap between environmental attitudes and behaviors. A hybrid care model, combining telemedicine and in-person visits, appears to be the most viable solution, balancing patient needs with environmental sustainability. This study supports integrating telemedicine into routine practice as a way to reduce the carbon footprint of healthcare and enhance accessibility. PLAIN LANGUAGE SUMMARY: This study explored whether telemedicine can reduce healthcare's environmental impact by looking at epilepsy follow-up care. A survey of 357 patients found that most preferred in-person visits (70%), while 26% favored a hybrid mix, and only 4% wanted telemedicine alone. Although digital literacy was generally high, and many cared about the environment, face-to-face care remained the preferred option. Patients valued saving travel time and avoiding infection risk with telemedicine but missed personal interaction and blood tests. The findings suggest a hybrid approach is best, offering flexibility, reducing travel emissions, and supporting sustainability while meeting patients' clinical and social needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.